Atossa Therapeutics (ATOS) traded down -5.77 % during a 24 hours period ending at 06:25 AM Central Europe on Tuesday 27th. One Atossa Therapeutics stock can currently be bought for about USD 2.45 on popular exchanges. Current supply of Atossa Therapeutics stocks is 10 mn. Atossa Therapeutics has a current market capitalization of USD 25.8 mn and approximately USD 86 k worth of Atossa Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Atossa Therapeutics has traded 25 % up. Simple moving average of last 200 days is at USD 4.09. The highest price of past 52 weeks was recorded at USD 14.85 on 12/11/2025. 52 weeks low was at USD 1.7 on 06/25/2026.
Here is how related stocks have performed in the past 24 hours:
Sharp Therapeutics (SHRX.V) traded flat 0 % and now trades at CAD 1.37. Sharp Therapeutics has a market capitalisation of CAD 43.3 mn.
Impact Biomedical (IBO) traded up 3.61 % and now trades at USD 3.73. Current market capitalisation for Impact Biomedical is USD 30.8 mn.
Metagenomi Therapeutics (MGX) traded down -4.84 % and now trades at USD 0.77. Current market capitalisation for Metagenomi Therapeutics is USD 30.4 mn.
Filana Therapeutics (FLNA) traded down -4.69 % and now trades at USD 0.61. Current market capitalisation for Filana Therapeutics is USD 30.4 mn.
Aardvark Therapeutics (AARD) traded down -22.3 % and now trades at USD 1.08. Aardvark Therapeutics has a market capitalisation of USD 30.4 mn.
About Atossa Therapeutics
Atossa Therapeutics, Inc. is a biopharmaceutical company that specializes in discovering proprietary therapeutics and delivery methods for breast cancer and related conditions. Based in Seattle, Washington, USA, the company operates globally, striving to provide innovative solutions to address unmet patient needs in the health care sector, particularly in the field of oncology.